(2026). KLF14 inhibits EMT in esophageal cancer cells through inhibition of the MISP-Wnt/β-catenin signaling axis. Discover Oncology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"KLF14 Inhibits EMT in Esophageal Cancer Cells Through Inhibition of the MISP-Wnt/β-catenin Signaling Axis."
Discover Oncology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"KLF14 Inhibits EMT in Esophageal Cancer Cells Through Inhibition of the MISP-Wnt/β-catenin Signaling Axis."
Discover Oncology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.